SUMOylation of TEAD1 Modulates the Mechanism of Pathological Cardiac Hypertrophy
Abstract Pathological cardiac hypertrophy is the leading cause of heart failure and has an extremely complicated pathogenesis. TEA domain transcription factor 1 (TEAD1) is recognized as an important transcription factor that plays a key regulatory role in cardiovascular disease. This study aimed to...
Main Authors: | Xin Shi, Xuening Dang, Zhenyu Huang, Yanqiao Lu, Huan Tong, Feng Liang, Fei Zhuang, Yi Li, Zhaohua Cai, Huanhuan Huo, Zhaolei Jiang, Changqing Pan, Xia Wang, Chang Gu, Ben He |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-03-01
|
Series: | Advanced Science |
Subjects: | |
Online Access: | https://doi.org/10.1002/advs.202305677 |
Similar Items
-
Sumoylation in synaptic function and dysfunction
by: Lenka eSCHOROVA, et al.
Published: (2016-04-01) -
SUMOylation in α-Synuclein Homeostasis and Pathology
by: Mor Savyon, et al.
Published: (2020-06-01) -
Current situation and future development of SUMOylation in ophthalmology
by: Bo Lu, et al.
Published: (2015-08-01) -
SUMOylation and Viral Infections of the Brain
by: Fergan Imbert, et al.
Published: (2022-07-01) -
SENP2 Promotes VSMC Phenotypic Switching via Myocardin De-SUMOylation
by: Min Liang, et al.
Published: (2022-10-01)